Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
We describe six patients (five women and one man; median age, 47 years; range, 39 to 54) with postprandial symptoms of neuroglycopenia owing to endogenous hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass surgery. Except for equivocal evidence in one patient, there was no radiologic evidence of insulinoma. Selective arterial calcium-stimulation tests, positive in each patient, were used to guide partial pancreatectomy. Nesidioblastosis was identified in resected specimens from each patient, and multiple insulinomas were identified in one. Hypoglycemic symptoms diminished postoperatively. We speculate that hyperfunction of pancreatic islets did not lead to obesity but that beta-cell trophic factors may have increased as a result of gastric bypass.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some persons who have undergone Roux-en-Y gastric bypass for obesity have endogenous hyperinsulinemic hypoglycemia most often due to pancreatic islet nesidioblastosis, but occasionally due to an insulinoma (48 -50).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [48]
In the citing paper
“However, it is the procedure of choice for confirming noninsulinoma pancreatogenous hypoglycemia (15,(43)(44)(45) and post Roux-en-Y gastric bypass hypoglycemia (48 -50) because standard imaging is negative in those disorders.”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [48]
In the citing paper
“post-RYGB hyperinsulinemic hypoglycemia may involve β-cell hypertrophy or neogenesis as well ( 80 , 81 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [80]
Citations
Cites
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2003-0323 · Cited by 664
Steinbrook, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048029 · Cited by 592
Brubaker, P. L., & Drucker, D. J. (2004) · Endocrinology · doi:10.1210/en.2004-0015 · Cited by 540
The Escalating Pandemics of Obesity and Sedentary Lifestyle: A Call to Action for Clinicians
Manson, J. E., Skerrett, P. J., Greenland, P., & VanItallie, T. B. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.249 · Cited by 504
Solcia, E., Capella, C., & Klöppel, G. (1997) · Medical Entomology and Zoology · Cited by 481
Zhou, J., Wang, X., Pineyro, M. A., & Egan, J. M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2358 · Cited by 319
Foulis, A. K. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199806)185:2<227::aid-path103>3.0.co;2-r · Cited by 212
Service, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5645 · Cited by 196
Self-citationSigstad, H. (1970) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1970.tb08072.x · Cited by 176
Research works printed but not linked: 3
- Threatte GA, Henry JB. Carbohydrates. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods. 19th ed. Philadelphia: W.B. Saunders, 1996:194-207.
- Kao PC, 1992, Ann Clin Lab Sci, 22, 307
- Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. Philadelphia: W.B. Saunders, 1999:750-808.
Cited by
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Self-citationRubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0236 · Cited by 1,008
Incretin hormones: Their role in health and disease
Nauck, M. A., & Meier, J. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13129 · Cited by 950
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Doyle, M. E., & Egan, J. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.007 · Cited by 680
The role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614
Heber, D., Greenway, F. L., Kaplan, L. M., Livingston, E., Salvador, J., & Still, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2128 · Cited by 521
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery
Thaler, J. P., & Cummings, D. E. (2009) · Endocrinology · doi:10.1210/en.2009-0367 · Cited by 443
Graaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., et al. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011395 · Cited by 403
Metabolic Surgery to Treat Type 2 Diabetes: Clinical Outcomes and Mechanisms of Action
Rubino, F., Schauer, P. R., Kaplan, L. M., & Cummings, D. E. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.051308.105148 · Cited by 381
Pathophysiology, diagnosis and management of postoperative dumping syndrome
Tack, J., Arts, J., Caenepeel, P., De Wulf, D., & Bisschops, R. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.148 · Cited by 387
“These patients were subsequently found to have pancreatic islet cell hyperplasia or nesidioblastosis on analysis of resected pancreatic specimens”
BackgroundMechanick, J. I., Kushner, R. F., Sugerman, H. J., Gonzalez-Campoy, J. M., Collazo-Clavell, M. L., Guven, S., Spitz, A. F., Apovian, C. M., Livingston, E. H., Brolin, R., et al. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.08.009 · Cited by 374
“[553] Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-”
BackgroundSelf-citationGoldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., & Patti, M. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0918 · Cited by 377
Mechanisms of diabetes improvement following bariatric/metabolic surgery
Batterham, R. L., & Cummings, D. E. (2016) · Diabetes Care · doi:10.2337/dc16-0145 · Cited by 376
Gastrointestinal hormones regulating appetite
Chaudhri, O., Small, C., & Bloom, S. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1856 · Cited by 346
Mechanick, J. I., Kushner, R. F., Sugerman, H. J., Gonzalez‐Campoy, J. M., Collazo‐Clavell, M. L., Spitz, A. F., Apovian, C. M., Livingston, E. H., Brolin, R., Sarwer, D. B., et al. (2009) · Obesity · doi:10.1038/oby.2009.28 · Cited by 345
Self-citationKorner, J., Bessler, M., Inabnet, W., Taveras, C., & Holst, J. J. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.08.004 · Cited by 344
International consensus on the diagnosis and management of dumping syndrome
Scarpellini, E., Arts, J., Karamanolis, G., Laurenius, A., Siquini, W., Suzuki, H., Ukleja, A., Van Beek, A., Vanuytsel, T., Bor, S., et al. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0357-5 · Cited by 306
Salehi, M., Prigeon, R. L., & D’Alessio, D. A. (2011) · Diabetes · doi:10.2337/db11-0203 · Cited by 323
Falkén, Y., Hellström, P. M., Holst, J. J., & Näslund, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2876 · Cited by 315
Bult, M. J. F., van Dalen, T., & Muller, A. F. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0145 · Cited by 301
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery
Madsbad, S., Dirksen, C., & Holst, J. J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70218-3 · Cited by 298
Blockade of Glucagon-like Peptide 1 Receptor Corrects Postprandial Hypoglycemia After Gastric Bypass
Salehi, M., Gastaldelli, A., & D'Alessio, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.044 · Cited by 289
Regulation of Glucose Homeostasis by GLP-1
Nadkarni, P., Chepurny, O. G., & Holz, G. G. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-800101-1.00002-8 · Cited by 287
Marsk, R., Jonas, E., Rasmussen, F., & Näslund, E. (2010) · Diabetologia · doi:10.1007/s00125-010-1798-5 · Cited by 273
“Recently hyperinsulinaemia and hypoglycaemia have been recognised as new complications of gastric bypass [ 3 , 4]. Patients have presented with hypoglycaemia associated with confusion, syncope and seizures attributed to changes in glucose homeostasis [5].”
BackgroundZiegler, O., Sirveaux, M. A., Brunaud, L., Reibel, N., & Quilliot, D. (2009) · Diabetes & Metabolism · doi:10.1016/s1262-3636(09)73464-0 · Cited by 244
“[22]—months or years after surgery.”
BackgroundMeier, J. J., Butler, A. E., Galasso, R., & Butler, P. C. (2006) · Diabetes Care · doi:10.2337/dc06-0392 · Cited by 249
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass
Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Jacobsen, S. H., Hansen, D. L., Worm, D., Holst, J. J., & Madsbad, S. (2012) · Diabetologia · doi:10.1007/s00125-012-2556-7 · Cited by 239
“The dramatic effect of RYGB on postprandial glucose tolerance was highlighted in 2005, when Service et al described six postoperative cases of hyperinsulinaemic hypoglycaemia with apparent nesidioblastosis severe enough to require partial pancreatectomy to control the symptoms [89].”
BackgroundMatveyenko, A. V., Dry, S., Cox, H. I., Moshtaghian, A., Gurlo, T., Galasso, R., Butler, A. E., & Butler, P. C. (2009) · Diabetes · doi:10.2337/db09-0058 · Cited by 242
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s008 · Cited by 244
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s008 · Cited by 244
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies
Salehi, M., Vella, A., McLaughlin, T., & Patti, M.-E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00528 · Cited by 239
Biologic actions and therapeutic potential of the proglucagon-derived peptides
Drucker, D. J. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0017 · Cited by 230
“Several recent reports have also linked increased circulating levels of GLP-1 with the development of nesidioblastosis and hypoglycemia in a small number of patients following gastric bypass, a finding that requires additional investigation”
BackgroundAmerican Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s008 · Cited by 236
Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment
Poitou Bernert, C., Ciangura, C., Coupaye, M., Czernichow, S., Bouillot, J. L., & Basdevant, A. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2006.11.004 · Cited by 235
“In particular we notice its damaging effect on dental state and mastication, hypoglycemia by pancreatic cell hyperplasia [10,11], functional complications (vomiting, bowel disorders, dumping syndrome).”
BackgroundIs Type 2 Diabetes an Operable Intestinal Disease?
Rubino, F. (2008) · Diabetes Care · doi:10.2337/dc08-s271 · Cited by 232
Dynkevich, Y., Rother, K. I., Whitford, I., Qureshi, S., Galiveeti, S., Szulc, A. L., Danoff, A., Breen, T. L., Kaviani, N., Shanik, M. H., et al. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1033 · Cited by 224
Kellogg, T. A., Bantle, J. P., Leslie, D. B., Redmond, J. B., Slusarek, B., Swan, T., Buchwald, H., & Ikramuddin, S. (2008) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2008.05.005 · Cited by 218
“[4], Patti et al.”
BackgroundInfluentialHofsø, D., Nordstrand, N., Johnson, L. K., Karlsen, T. I., Hager, H., Jenssen, T., Bollerslev, J., Godang, K., Sandbu, R., Røislien, J., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0514 · Cited by 207
Khatua, B., El-Kurdi, B., & Singh, V. P. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000386 · Cited by 206
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s008 · Cited by 213
Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss
Holst, J. J., Madsbad, S., Bojsen-Møller, K. N., Svane, M. S., Jørgensen, N. B., Dirksen, C., & Martinussen, C. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.03.003 · Cited by 202
Dedov, I. I., Mel'nichenko, G. A., Shestakova, M. V., Troshina, E. A., Mazurina, N. V., Shestakova, E. A., Yashkov, Y. I., Neimark, A. E., Biryukova, E. V., Bondarenko, I. Z., et al. (2018) · Obesity and metabolism · doi:10.14341/omet2018153-70 · Cited by 173
Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery
Cummings, D. E. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.15 · Cited by 199
Vilarrasa, N., Goday, A., Rubio, M. A., Caixàs, A., Pellitero, S., Ciudin, A., Calañas, A., Botella, J. I., Bretón, I., Morales, M. J., et al. (2016) · Obesity Facts · doi:10.1159/000442764 · Cited by 197
Mechanick, J. I., Kushner, R. F., Sugerman, H. J., Gonzalez-Campoy, J. M., Collazo-Clavell, M. L., Guven, S., Spitz, A. F., Apovian, C. M., Livingston, E. H., Brolin, R., et al. (2008) · Endocrine Practice · doi:10.4158/ep.14.s1.1 · Cited by 193
Self-citationFerrannini, E., & Mingrone, G. (2009) · Diabetes Care · doi:10.2337/dc08-1762 · Cited by 194
Summit, O. B. O. T. D. O. T. 2. D. S., Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., et al. (2017) · Obesity Surgery · doi:10.1007/s11695-016-2457-9 · Cited by 189
Roux‐en‐Y Gastric Bypass Enhances Energy Expenditure and Extends Lifespan in Diet‐induced Obese Rats
Stylopoulos, N., Hoppin, A. G., & Kaplan, L. M. (2009) · Obesity · doi:10.1038/oby.2009.207 · Cited by 187
Mineral Malnutrition Following Bariatric Surgery
Gletsu-Miller, N., & Wright, B. N. (2013) · Advances in Nutrition · doi:10.3945/an.113.004341 · Cited by 181
Öberg, K. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.014 · Cited by 189
McLaughlin, T., Peck, M., Holst, J., & Deacon, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1628 · Cited by 183
Mechanisms of early improvement / resolution of type 2 diabetes after bariatric surgery
Mingrone, G., & Castagneto-Gissey, L. (2009) · Diabetes & Metabolism · doi:10.1016/s1262-3636(09)73459-7 · Cited by 170
“Also, sporadic cases of nesidioblastosis have been reported after RYGB for morbid obesity [36,37].”
BackgroundNauck, M. A., Vilsbøll, T., Gallwitz, B., Garber, A., & Madsbad, S. (2009) · Diabetes Care · doi:10.2337/dc09-s315 · Cited by 169
Lee, W.-J., Ser, K.-H., Chong, K., Lee, Y.-C., Chen, S.-C., Tsou, J.-J., Chen, J.-C., & Chen, C.-M. (2010) · Surgery · doi:10.1016/j.surg.2009.10.059 · Cited by 175
Surgery on neuroendocrine tumours
Åkerström, G., & Hellman, P. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.12.004 · Cited by 172
Possible risk factors for increased suicide following bariatric surgery
Mitchell, J. E., Crosby, R., de Zwaan, M., Engel, S., Roerig, J., Steffen, K., Gordon, K. H., Karr, T., Lavender, J., & Wonderlich, S. (2013) · Obesity · doi:10.1002/oby.20066 · Cited by 162
Intrinsic Regulators of Pancreatic β-Cell Proliferation
Heit, J. J., Karnik, S. K., & Kim, S. K. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104425 · Cited by 165
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s008 · Cited by 149
Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review
Abdeen, G., & le Roux, C. (2016) · Obesity Surgery · doi:10.1007/s11695-015-1945-7 · Cited by 162
“Although treatment of this complication can be difficult, pancreatectomies are no longer advised [170], but rather a multimodal medical approach is favoured [171].”
BackgroundLee, C. J., Clark, J. M., Schweitzer, M., Magnuson, T., Steele, K., Koerner, O., & Brown, T. T. (2015) · Obesity · doi:10.1002/oby.21042 · Cited by 159
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s008 · Cited by 158
Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.05.018 · Cited by 157
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s008 · Cited by 148
Patriti, A., Aisa, M. C., Annetti, C., Sidoni, A., Galli, F., Ferri, I., Gullà, N., & Donini, A. (2007) · Surgery · doi:10.1016/j.surg.2007.03.001 · Cited by 170
Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35
DePaula, A. L., Macedo, A. L. V., Rassi, N., Machado, C. A., Schraibman, V., Silva, L. Q., & Halpern, A. (2007) · Surgical Endoscopy · doi:10.1007/s00464-007-9472-9 · Cited by 170
“Furthermore, the potential incretin effect from moving ileum proximally may cause hypertrophy of the pancreas, with attendant nesidioblastosis [ 47 ].”
BackgroundKefurt, R., Langer, F. B., Schindler, K., Shakeri‐Leidenmühler, S., Ludvik, B. H., & Prager, G. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.11.003 · Cited by 161
Metabolic surgery and cancer: Protective effects of bariatric procedures
Ashrafian, H., Ahmed, K., Rowland, S. P., Patel, V. M., Gooderham, N. J., Holmes, E., Darzi, A., & Athanasiou, T. (2011) · Cancer · doi:10.1002/cncr.25738 · Cited by 149
Kauhanen, S., Seppänen, M., Minn, H., Gullichsen, R., Salonen, A., Alanen, K., Parkkola, R., Solin, O., Bergman, J., Sane, T., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1479 · Cited by 152
Clinical Management After Bariatric Surgery: Value of a Multidisciplinary Approach
McMahon, M. M., Sarr, M. G., Clark, M. M., Gall, M. M., Knoetgen, J., Service, F. J., Laskowski, E. R., & Hurley, D. L. (2006) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61179-8 · Cited by 167
Self-citationMoreira, R., Moreira, R. B. M., Machado, N. A. M., Gonçalves, T. B., & Coutinho, W. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9569-9 · Cited by 136
“A few years later, the same authors described a new complication of the Roux-en-Y gastric bypass surgery, characterized by an excessive and pathological growth of pancreatic beta cells (nesidioblastoses), leading to a severe hyperinsulinemic hypoglycemia [4].”
BackgroundMethodInfluentialRole of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery
Cummings, D. E., Overduin, J., Foster-Schubert, K. E., & Carlson, M. J. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.02.003 · Cited by 140
Sarma, S., & Palcu, P. (2022) · Obesity · doi:10.1002/oby.23563 · Cited by 133
Clancy, T. E., Moore, F. D., & Zinner, M. J. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.04.008 · Cited by 133
ASMBS Position Statement on Postprandial Hyperinsulinemic Hypoglycemia after Bariatric Surgery
Eisenberg, D., Azagury, D. E., Ghiassi, S., Grover, B. T., & Kim, J. J. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.12.005 · Cited by 147
Salehi, M., Gastaldelli, A., & D'Alessio, D. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2686 · Cited by 130
Incidence of Hypoglycemia After Gastric Bypass vs Sleeve Gastrectomy: A Randomized Trial
Capristo, E., Panunzi, S., De Gaetano, A., Spuntarelli, V., Bellantone, R., Giustacchini, P., Birkenfeld, A. L., Amiel, S., Bornstein, S. R., Raffaelli, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01695 · Cited by 122
Hyperinsulinaemic hypoglycaemia in children and adults
Shah, P., Rahman, S. A., Demirbilek, H., Güemes, M., & Hussain, K. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30323-0 · Cited by 132
Severe Recurrent Hypoglycemia after Gastric Bypass Surgery
Z’graggen, K., Guweidhi, A., Steffen, R., Potoczna, N., Biral, R., Walther, F., Komminoth, P., & Horber, F. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9480-4 · Cited by 125
“Recently, a severe recurrent symptomatic hypoglycemia was shown to occur as a consequence of gastric bypass surgery in a small series of patients with morbid obesity [ 18 ].”
BackgroundCritical role for GLP-1 in symptomatic post-bariatric hypoglycaemia
Craig, C. M., Liu, L.-F., Deacon, C. F., Holst, J. J., & McLaughlin, T. L. (2017) · Diabetologia · doi:10.1007/s00125-016-4179-x · Cited by 120
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s008 · Cited by 165
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s007 · Cited by 117
Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia of Infancy
Hussain, K. (2007) · Hormone Research in Paediatrics · doi:10.1159/000111789 · Cited by 119
Adult diffuse nesidioblastosis: genetically or environmentally induced?
Klöppel, G., Anlauf, M., Raffel, A., Perren, A., & Knoefel, W. T. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.09.010 · Cited by 108
Advances in the diagnosis and management of hyperinsulinemic hypoglycemia
Kapoor, R. R., James, C. T., & Hussain, K. (2009) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1046 · Cited by 113
“in those who have undergone gastric bypass surgery for morbid obesit”
Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1
Riddle, M. C., & Drucker, D. J. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1267 · Cited by 109
Won, J. G. S., Tseng, H., Yang, A., Tang, K., Jap, T., Lee, C. H., Lin, H., Burcus, N., Pittenger, G., & Vinik, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02629.x · Cited by 109
MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia
Kittah, N. E., & Vella, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1062 · Cited by 107
de Paula, A. L., Macedo, A. L. V., Prudente, A., Queiroz, L., Schraibman, V., & Pinus, J. (2006) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2006.03.005 · Cited by 107
Bariatric surgery for type 2 diabetes: Weighing the impact for obese patients
Kashyap, S. R., Gatmaitan, P., Brethauer, S. A., & Schauer, P. R. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.09135 · Cited by 119
Campos, G. M., Ziemelis, M., Paparodis, R., Ahmed, M., & Belt Davis, D. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.05.012 · Cited by 104
“In patients with recalcitrant postRYGB hyperinsulinemic hypoglycemia, surgical treatment with subtotal or total pancreatectomy has been offered in selected cases [11,12], because the condition has been linked to de novo postRYGB nesidioblastosis or pancreatic islet overgrowth as its potential cause [12].”
BackgroundDiabetes resolution and hyperinsulinaemia after metabolic Roux‐en‐Y gastric bypass
Ashrafian, H., Athanasiou, T., Li, J. V., Bueter, M., Ahmed, K., Nagpal, K., Holmes, E., Darzi, A., & Bloom, S. R. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00802.x · Cited by 95
Contraceptive use among women with a history of bariatric surgery: a systematic review
Paulen, M. E., Zapata, L. B., Cansino, C. D., Curtis, K. M., & Jamieson, D. J. (2010) · Contraception · doi:10.1016/j.contraception.2010.02.008 · Cited by 102
“Short-term complications, including postoperative complications, include but are not limited to pulmonary embolism/venous thromboembolism, anastomotic leak, wound infection, incisional hernia, vomiting, dumping syndrome, upper gastrointestinal obstruction, and endogenous hyperinsulinemic hypoglycemia with nesidioblast…”
BackgroundLong-Term Results of Laparoscopic Roux-en-Y Gastric Bypass: Evaluation After 9 Years
HIMPENS, J. M., Verbrugghe, A., Cadière, G.-B., Everaerts, W., & Greve, J.-W. M. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0707-z · Cited by 103
“More radical options include pancreatic resections as initially proposed [59], but the use of such formidable surgery is questionable because neuroglycopenia is usually not caused by a pancreatic cell hyperplasia [60].”
Background
Metadata
- Authors
- Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V.
- Affiliations
- Mayo Clinic (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-07-21
- Volume
- 353
- Issue
- 3
- Pages
- 249-254
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2134703404
- Semantic Scholar
- 0c597199a9be21ad0a99933c6f411731493880d4
- Cited by
- 779
- References
- 26
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 18 · 2022: 22 · 2021: 23 · 2020: 27 · 2019: 27 · 2018: 31 · 2017: 35 · 2016: 51 · 2015: 59 · 2014: 50 · 2013: 40 · 2012: 57
- FWCI
- 40.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (32385)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- hyperinsulinemic hypoglycemia, nesidioblastosis, Roux-en-Y gastric bypass, postprandial hypoglycemia, neuroglycopenia, partial pancreatectomy, insulinoma, obesity
- MeSH terms
- Adult, Female, Follow-Up Studies, Humans, Hyperinsulinism, Hyperplasia, Hypoglycemia, Insulinoma, Islets of Langerhans, Male, Middle Aged, Obesity, Obesity, Morbid, Pancreatic Ducts, Pancreatic Neoplasms, Postoperative Complications, Gastric Bypass, Postprandial Period, Nesidioblastosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.